Skip to main content
. 2017 Aug 4;22(10):1149–1151. doi: 10.1634/theoncologist.2017-0096

Figure 1.

image

Programmed death‐ligand 1/PD‐1 interaction mediates inhibition of T‐cell mediated tumor cell killing. Blockade of PD‐L1 with nivolumab results in reactivation of T‐cell mediated tumor cell killing.

Abbreviations: CTLA‐4, cytotoxic T‐lymphocyte‐associated protein 4; MHC, major histocompatibility complex; PD‐1, programmed death 1; PD‐L1, programmed death‐ligand 1 (CD274 or B7‐H1 protein); TCR, T‐cell receptor.